NCT06703697 Effectiveness and Implementation of Mobile Health Platform for Medication Management and E-Labeling (eDrugSafe)
| NCT ID | NCT06703697 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University |
| Condition | Mobile Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2024-08-12 |
| Primary Completion | 2024-12-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2024-08-12 with a primary completion date of 2024-12-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this cluster randomized trial is to learn if eDrugSafe, a mobile web platform for drug electronic labeling (e-labeling) and medication management, can improve medication adherence and self-efficacy in adults who take multiple medications. This study will also assess whether eDrugSafe is feasible and acceptable for use in real clinical settings, especially in local pharmacies. The main questions it aims to answer are: * Can eDrugSafe improve medication adherence, self-efficacy, and quality of life for adults taking multiple medications and reduce hospitalizations? * Is eDrugSafe acceptable and feasible for implementing drug e-labeling and supporting medication management in community settings? Researchers will compare eDrugSafe to usual care (traditional paper methods) to see if eDrugSafe is effective in supporting adults who take multiple medications, and if it can be feasibly implemented in local pharmacies. Participants will: * Visit a local pharmacy randomly assigned to use eDrugSafe or traditional care methods and decide if they wish to join the study. * Use either eDrugSafe to access medication information and manage their medication history, or receive usual care with paper-based methods, for 6 months. * Complete surveys at the start of the study, at 3 months, and at 6 months to measure effectiveness and implementation outcomes.
Eligibility Criteria
Inclusion Criteria: 1. Adults aged 18 to 79 years. 2. Individuals who can speak and understand Korean. 3. Possession of a personal electronic device capable of accessing mobile applications and web services over wireless internet (bring participants' own device, BYOD). 4. Patients taking three or more medications with at least one medication prescribed for 28 days or longer. 5. Individuals who have provided direct consent to participate in the study. Exclusion Criteria: 1. Individuals using any mobile web platform other than eDrugSafe for medication safety information purposes after enrollment. 2. Individuals who do not consent to participate in the study or who withdraw their consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06703697 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 79 Years, studying Mobile Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06703697 currently recruiting?
Yes, NCT06703697 is actively recruiting participants. Contact the research team at jmoh@snu.ac.kr for enrollment information.
Where is the NCT06703697 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06703697 clinical trial?
NCT06703697 is sponsored by Seoul National University. The trial plans to enroll 360 participants.